IPM does not have a broad set of current analyst price targets, so the $2.20 objective draws from the stock's recent trading range and market structure. The 52-week span runs from about $1.37 to $2.19, making the upper end a commonly watched resistance point and prior high that technical observers often reference as a logical recovery mark.
The sole published target comes from Maxim Group's Allen Klee at $6.50 with a Buy rating. That figure lies roughly 280% above recent prices and reflects one firm's longer-term outlook, so it is noted for context but not used as the primary target. Single-analyst estimates on thinly covered micro-caps warrant careful handling.
Shares have been trading near $1.70, so a move to $2.20 would require an advance of about 29%. That is a sizable shift for a micro-cap averaging only a few thousand shares in daily volume. Fiscal 2025 revenue reached $23.6 million, with first-quarter 2026 revenue rising 15% year over year to $6.4 million and second-quarter revenue up 13% to $6.5 million, supported by managed IT and procurement sales linked to AI infrastructure needs.
The company is still reporting net losses, including roughly $1.35 million in the second quarter of 2026. Management has noted positive adjusted EBITDA in the fourth quarter of 2025 and is targeting a return to positive adjusted EBITDA in the fourth quarter of 2026. I also checked this using Tickeron’s AI Screener to compare IPM’s metrics against peers in the sector. Achieving the $2.20 level would likely need continued revenue expansion, margin gains, and a market re-rating from its current position in the lower half of the 52-week range.
Several elements could lend support. Core managed IT revenue grew 19% in the first quarter of 2026 and remains the main growth driver. The company finished the second quarter with about $7.5 million in cash and no long-term debt, offering room for organic investment or acquisitions in the consolidating managed-services space. SOC 2 Type 1 compliance has also improved its standing with regulated clients.
Two longer-term items stand out as well. Management has flagged a pending patent judgment against Cisco that could bring meaningful proceeds in 2027, while strategic AI partnerships and the in-house IPM GO platform are intended to broaden offerings. A positive outcome on either could lift sentiment for a stock with limited institutional interest so far.
The challenges are real. IPM is still a loss-making micro-cap with a market capitalization around $14 million and very thin trading volume, which can make price discovery inefficient and heighten volatility. A notable share of revenue comes from NewtekOne, a related party that has been trimming its IT spending and thus creates concentration risk. Professional services and legacy subscription revenue have been declining, which offsets some of the managed-IT gains.
Supply-chain issues around memory, CPUs, and GPUs have delayed procurement revenue and pressured margins recently. Research coverage is limited to one analyst, leaving little institutional sponsorship to support a sustained re-rating. Any delay in profitability improvements or an unfavorable turn in the Cisco patent matter could weigh on the shares.
The $2.20 area sits right at the 52-week high of roughly $2.19 and acts as the main resistance above current prices. Clearing that zone on a sustained basis would mean moving past a prior supply area that has capped rallies in the past. On the downside, the 52-week low near $1.37 serves as key support, with the stock currently sitting in the middle of the range. Given the thin liquidity, these levels are best viewed as zones rather than exact turning points.
Analyst targets usually cover a 12-month window, though the $6.50 figure from Maxim Group appears tied to a multi-year view centered on the Cisco litigation. For the technical milestone at $2.20, no fixed horizon applies. I’m watching quarterly revenue trends and the path of adjusted EBITDA closely, along with updates on the Cisco patent case, AI-related procurement demand, and any shifts in the limited analyst coverage. Related-party revenue from NewtekOne also deserves attention.
AI Daily Buy/Sell Signals from Tickeron apply artificial intelligence to track thousands of stocks and ETFs, producing Buy, Sell, or Hold signals as market conditions and technical behavior shift. For a low-liquidity name like IPM, these signals can help identify trend changes more efficiently than manual review alone. Traders can use the platform to spot opportunities, monitor positions, and respond to momentum shifts with greater speed.
The $2.20 target represents a technical milestone—the stock’s 52-week high—rather than an analyst consensus, and reaching it would mean a gain of about 29% from recent levels. Support could come from steady managed-IT growth, a debt-free balance sheet, improving profitability, and a possible Cisco patent payout. Countering that are persistent net losses, thin liquidity, related-party concentration, and minimal analyst sponsorship. The lone $6.50 target reflects a more aggressive, longer-horizon scenario and should not be viewed as a near-term benchmark. No outcome is assured, and investors need to balance operational progress against these structural risks.
In my own research on names like IPM, I have found AI Daily Buy/Sell Signals helpful for spotting momentum shifts in low-volume stocks. The tool scans thousands of securities daily and can surface ideas that complement manual analysis. It is one resource I turn to when evaluating technical setups or trend changes across the broader market.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The RSI Oscillator for IPM moved out of oversold territory on November 02, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 19 similar instances when the indicator left oversold territory. In 17 of the 19 cases the stock moved higher. This puts the odds of a move higher at 89%.
The Moving Average Convergence Divergence (MACD) for IPM just turned positive on November 06, 2026. Looking at past instances where IPM's MACD turned positive, the stock continued to rise in 37 of 43 cases over the following month. The odds of a continued upward trend are 86%.
Following a +3.53% 3-day Advance, the price is estimated to grow further. Considering data from situations where IPM advanced for three days, in 196 of 229 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
IPM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IPM as a result. In 91 of 103 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.
The 50-day moving average for IPM moved below the 200-day moving average on November 04, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IPM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
The Aroon Indicator for IPM entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 21 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.380) is normal, around the industry mean (-1.906). P/E Ratio (-6.107) is within average values for comparable stocks, (9.554). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.824). Dividend Yield (0.000) settles around the average of (0.069) among similar stocks. P/S Ratio (0.982) is also within normal values, averaging (70.383).
The Tickeron PE Growth Rating for this company is 39 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 69 (best 1 - 100 worst), indicating slightly worse than average price growth. IPM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IPM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry PackagedSoftware